Season 04: episode 07
This week on the GOLD podcast, Isabel is joined by Matt Lewis, Co-Founder, Inizio Medical Analytics and Innovation, to discuss the future of AI in the pharmaceutical industry and the potential uses of ChatGPT in medical affairs and other functions.
In this episode, Matt explores the need to modernise medical affairs, top ways pharma teams could save time and resources with ChatGPT, the likelihood of AI one day becoming as commonplace as electricity and much more.
A little more on GOLD’s guest…
Matt Lewis is Co-Founder, Inizio Medical Analytics and Innovation. Based in New York, he leads a team dedicated to transforming innovation in the life sciences. Prior to Inizio, Matt worked at Procter & Gamble, Boehringer Ingelheim and a number of medical communications agencies, and his experience spans most major therapeutic areas. Matt also holds four degrees, including one in Molecular Biology from Cornell University and one in Population Health from New York University. When not at work, Matt advises emerging startups in the disruptive innovation space and judges open innovation competitions for government and private funders. He also spends as much time as possible volunteering in the community, spending time with his friends and loved ones, reading, enjoying good food and music and walking in nature.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: